For ovarian cancer, depletion of sphingomyelin synthase 2, which controls SM content, has been shown to suppress survival, growth, and migration of cell lines via disruption of lipid metabolism and mitochondrial function [58]. This evidence concerns the gene SGMS2 and ovarian carcinoma.